Soluble TREM2 distinguishes neuromyelitis optica spectrum disorder from MOG antibody disease.

Bibliographic Details
Title: Soluble TREM2 distinguishes neuromyelitis optica spectrum disorder from MOG antibody disease.
Authors: Chuquisana, Omar1 (AUTHOR), Spatola, Marianna2,3 (AUTHOR), Dinoto, Alessandro4 (AUTHOR), Sepúlveda, María2,3 (AUTHOR), Mariotto, Sara4 (AUTHOR), Tintore, Mar5,6 (AUTHOR), Montalban, Xavier5,6 (AUTHOR), Comabella, Manuel5 (AUTHOR), Lünemann, Jan D1 (AUTHOR)
Source: Brain: A Journal of Neurology. Feb2025, Vol. 148 Issue 2, pe4-e7. 4p.
Subject Terms: *NEUROMYELITIS optica, *MYELIN oligodendrocyte glycoprotein antibody-associated disease, *MYELIN oligodendrocyte glycoprotein, *PATHOLOGY, *RECEIVER operating characteristic curves
Database: Academic Search Complete
More Details
ISSN:00068950
DOI:10.1093/brain/awae335
Published in:Brain: A Journal of Neurology
Language:English